Fundai

Alborz Bulk Pharmaceutical Raw Materials Company (DBALK) cash flow statement

Operating, investing and financing cash flows, and the closing balance

Ticker
DBALK
Industry
Pharmaceuticals
Market
Iran Fara Bourse

Latest periods

Latest 9-month periods, in million rials
ItemTo 1405/06/31To 1404/06/31To 1403/06/31To 1402/06/31To 1401/06/31To 1400/06/31
Cash generated from operations2,084,377-855,818452,372-538,763-205,17986,599
Cash payments for income tax-104,096-25,401-230,742-51,156-65,085-72,539
Net cash inflow (outflow) from operating activities1,980,281-881,219221,630-589,919-270,26414,060
Cash payments for purchase of property, plant and equipment-384,642-132,966-77,245-106,790-104,720-64,561
Cash payments for purchase of intangible assets-17,37500-10,890-8,300-3,696
Cash receipts from interest on other investments7,8981,6612374,08775410,953
Net cash inflow (outflow) from investing activities-394,119-128,557-71,284-109,081-112,266-53,086
Net cash inflow (outflow) before financing activities1,586,162-1,009,776150,346-699,000-382,530-39,026
Cash receipts from facilities7,011,0602,775,0002,725,7433,221,0002,138,017710,506
Cash payments for principal of loans-3,857,984-1,705,870-2,029,944-1,280,220-1,373,125-572,853
Cash payments for interest on loans-609,494-919,850-792,835-629,607-186,627-113,719
Cash payments for dividends-482,974-23,660-20,380-520,147-66,906-12,272
Net cash inflow (outflow) from financing activities2,060,6081,075,423-127,416800,435464,687-5,072
Net increase (decrease) in cash3,646,77065,64722,930101,43582,157-44,098
Cash balance at beginning of year868,170130,29431,97857,66159,334168,979
Cash balance at end of year4,514,940195,94154,908159,096141,491124,881

Reporting periods

52 periods are on file for this report, from the period ending 1390/12/29 to the period ending 1405/06/31.